Cardiac Biomarkers Market Growing Trade Among Emerging Economies

Posted by vinit sawant on March 16th, 2021

The cardiac biomarkers market is pervasively growing at a rapid pace. Market growth attributes to the evolving biomarker technology led by increased research and development activities and substantial investments

According to Market Research Future (MRFR), the global cardiac biomarkers market size is expected to reach USD 4236.02 MN by 2025, registering 16.36% CAGR throughout the forecast period (2019-2025). The increasing adoption of outsourcing services is a recent trend in the market.

Also, factors such as the availability of other efficient methods for the diagnosis of cardiovascular diseases and the high cost of biomarkers hamper the growth of the market. Nevertheless, government grants and initiatives released to drive required R&D activities in the field would support the market growth throughout the predicted period. Besides, the availability of affordable treatment options for advanced cardiac treatments propels the growth of the market.

Cardiac Biomarkers Market – Regional Analysis

North America dominates the global cardiac biomarkers market. The largest market share attributes to the high prevalence of cardiac diseases and coronary heart disease (CHD) and contributions from the strongly expanding US cardiac biomarkers market. Besides, factors such as rapid research & development initiatives and substantial R&D investments in the field of biomarkers foster regional market growth.

India and China provide immense growth opportunities to the cardiac biomarkers market, accounting for the vast population and large unmet clinical needs. Furthermore, raising awareness about the availability of new treatment methods and improving living standards of demographics propel the growth of the APAC cardiac biomarkers market.

Like it? Share it!


vinit sawant

About the Author

vinit sawant
Joined: July 4th, 2019
Articles Posted: 359

More by this author